The origin of coronary endothelial cells (ECs) has been investigated in avian species, and the results showed that the coronary ECs originate from the proepicardial organ (PEO) and developing epicardium. Genetic approaches in mouse models showed that the major source of coronary ECs is the sinus venosus endothelium or ventricular endocardium. To clarify and reconcile the differences between avian and mouse species, we examined the source of coronary ECs in avian embryonic hearts. Using an enhanced green fluorescent protein-Tol2 system and fluorescent dye labeling, four types of quail-chick chimeras were made and quail-specific endothelial marker (QH1) immunohistochemistry was performed. The developing PEO consisted of at least two cellular populations in origin, one was sinus venosus endothelium-derived inner cells and the other was surface mesothelium-derived cells. The majority of ECs in the coronary stems, ventricular free wall, and dorsal ventricular septum originated from the sinus venosus endothelium. The ventricular endocardium contributed mainly to the septal artery and a few cells to the coronary stems. Surface mesothelial cells of the PEO differentiated mainly into a smooth muscle phenotype, but a few differentiated into ECs. In avian species, the coronary endothelium had a heterogeneous origin in a region-specific manner, and the sources of ECs were basically the same as those observed in mice.
| INTRODUCTION
Coronary vessels function to supply oxygen and nutrients to the cardiac muscle to maintain the heartbeat. During heart development in the early embryonic stages, oxygen and nutrients are supplied to the myocardium by diffusion through the inner endocardium. At the onset of the fetal stage, endothelial cells (ECs) from the peritruncal endothelial plexus invade into the aortic sinuses to form coronary stems, thereafter coronary circulation starts and continues throughout life (Ando, Nakajima, Yamagishi, Yamamoto, & Nakamura, 2004) . Disruption of coronary circulation causes ischemic heart disease including angina pectoris and myocardial infarction. Improved understanding of the developmental biology of coronary vessels is necessary to develop therapeutic strategies for revascularization of the ischemic heart.
The coronary artery consists of three distinct layers, the tunica interna, tunica media, and tunica externa. It is well accepted that not only vascular smooth muscle cells of the tunica media but also interstitial cells of the tunica externa originate from the developing epicardium. The developing epicardium is a derivative of the proepicardial organ (PEO), which is a cauliflower-shaped protrusion extending from the mesothelial layer covering the ventral surface of the sinus venosus (SV) (Dettman, Denetclaw, Ordahl, & Bristow, 1998; Hiruma & Hirakow, 1989; Mikawa & Fischman, 1992; Mikawa & Gourdie, 1996) . The developing epicardium undergoes epithelialto-mesenchymal transition to seed subepicardial mesenchymal cells, which later give rise to vascular smooth muscle and interstitial cells (Dettman et al., 1998; Mikawa & Gourdie, 1996) . Genetic cell-tracing experiments in mouse embryos showed that the major source of coronary ECs is the SV endothelium and/or ventricular endocardium (Chen et al., 2014; Red-Horse, Ueno, Weissman, & Krasnow, 2010; Tian, Pu, & Zhou, 2015; Tian et al., 2013; Wu et al., 2012; Zhang et al., 2016) . In the neonatal mouse heart, ventricular endocardium contributes to form the subendocardial coronary vasculatures (Tian et al., 2015) . In avian hearts, retrovirus cell-tracing, quail-chick chimera, and dye-marking experiments showed that cells from the PEO differentiate into the epicardium, vascular smooth muscle, and coronary endothelium (Männer, 1999; Mikawa & Fischman, 1992; Pérez-Pomares et al., 2002) . The discrepancy of the origin of coronary ECs between mouse and avian species as well as among mouse models is an unresolved issue.
The PEO is a transient tissue consisting of surface mesothelium and inner mesenchymal-like populations. Matured PEO adheres to the dorsal surface of the atrioventricular groove and spreads over the heart in a dorsal-to-ventral direction to generate the epicardium (Hiruma & Hirakow, 1989; Nakajima & Imanaka-Yoshida, 2013 ). In the mouse PEO, a Scleraxis-/Semaphorin3D-expressing population gives rise to coronary ECs, whereas Tbx18/Wt1-positive surface mesothelial cells provide the epicardium, vascular smooth muscle, and myocardial interstitial cells (Katz et al., 2012) . In the avian PEO, hematopoietic-and endothelial-marker positive cells are observed just before attaching to the ventricle (Guadix, Carmona, Munoz-Chapuli, & PerezPomares, 2006; Kattan, Dettman, & Bristow, 2004; Niderla-Bielinska et al., 2015; Poelmann, Gittenberger-de Groot, Mentink, Bokenkamp, & Hogers, 1993) . The origin and nature of the inner hemangioblast-like population remain uncertain.
In the present study, using enhanced green fluorescent protein (EGFP)-Tol2 and fluorescent dye labeling in combination with quailchick chimera, we examined the origin of coronary ECs and the relative contributions of their distinct sources for coronary vessels. The results showed that cells from the SV endothelium migrated into the PEO, subepicardial space, and ventricular wall, and contributed to coronary vessels in the ventricular free wall including coronary stems. Ventricular endocardium contributed mainly to the septal coronary vessels. The surface mesothelial cells of the PEO differentiated into coronary smooth muscle cells but a few of them also contributed to the coronary endothelium.
| MATERIALS AND METHODS

| Chick and quail embryos
Fertilized eggs (chick [Gallus gallus], Shiroyama Farm, Kanagawa, Japan; quail [Coturnix japonica], Quail Cosmos, Aichi, Japan) were incubated at 37°C and 60% humidity. After an appropriate incubation period, 4 ml (1 ml in quail) of egg albumin was removed and a fenestration (1.5 × 2 cm) (1 × 1 cm in quail) was made, followed by injection of 10% carbon ink/Tyrode's solution into the yolk sac beneath the embryo, and staged in accordance with Hamburger and Hamilton (Hamburger & Hamilton, 1951) . Embryos were subjected to EGFPTol2 or dye labeling as well as chimera generation. Animal handling and procedures were approved by the Osaka City University Animal Care and Use Committee, as set forth in the NIH Guide for the Care and Use of Laboratory Animals (Eighth Edition).
| Preparation of EGFP-Tol2 transfection mixture
To label the target cells across the cell cycles, transfection of the EGFP- (kindly donated by Dr Takahashi, Kyoto University) (Sato et al., 2007) were diluted with Opti-MEM I (0.28 μg/μl). The same amounts of diluted Lipofectamine 2000 and DNA were mixed gently and incubated for 20 min at room temperature. The resulting transfection mixture, which contained pCAGGS-T2TP (0.14 μg/μl), pT2K-CAGGS-EGFP (0.14 μg/μl) and Lipofectamine 2000 (0.4 μl/μl) (0.075%), was used for labeling experiments.
| Fluorescent labeling in ovo
To label the SV ECs, 2 μl of acetylated low-density lipoprotein labeled with 1,1′-dioctadecyl-3,3,3′,3-tetramethylindo-carbocyani ne perchlorate (DiI-LDL; 100 μg/ml in 0.05% fast green/phosphatebuffered saline [PBS] ; Biomedical Technologies Inc., MA, USA) was slowly injected into the peripheral vitelline vein of stage 14-15 embryos using a sharpened pulled-glass needle (10-20 μm in external diameter) equipped with a pressure injector (NARISHIGE, Tokyo, Japan). To label the surface mesothelial cells of the PEO, 2 μl of 5-and 6-carboxyfluorescein diacetate succinimidyl ester (CFSE; 100 μmol/L in Tyrode's solution, Bioquest, CA, USA) (Kruithof et al., 2006) or 0.1-1 μl of EGFP-Tol2 transfection mixture was slowly microinjected into the pericardial cavity of stage 13-14 embryos using the pressure injector. To label the chick ventricular endocardium or quail SV endothelium, 0.1-0.2 μl of EGFP-Tol2 transfection mixture was slowly microinjected into the ventricle, atrium, or SV of cold-induced arrested hearts at stage 12. Embryos were left for 1 hr at room temperature.
After an additional incubation period at 37°C, embryos were subjected to quail-chick chimera or organ culture. Fluorescently labeled target cells (ECs and mesothelial cells) and the labeling efficiency of EFGP-Tol2 system were shown in Figure S1 .
| Quail-chick chimera
Four types of quail-chick chimera were prepared in accordance with a modified method described by Männer ( Figure 1 ) (Männer, 1999) .
To define the cranio-caudal orientation of the PEO, a small long pentagonal-shaped eggshell membrane was inserted into the stage 16-17 quail SV posterior to the PEO. SV with the PEO, and eggshell membrane were carefully extirpated and transplanted orthotopically into the host chick embryo. To avoid contamination of host SV ECs and PEO cells into the chimeric heart, the host chick PEO was cauterized using a small vessel cauterizer before transplantation (FST Inc., at stage 12 (n = 3, Figure 1d ). Number of chimeric hearts examined was summarized in Table S1 . There was no obvious cardiac anomaly except an adherent transplanted tissue on the dorsal surface of the atrioventricular region. We reported previously that PEO-deleted embryos die before stage 31 because of defective epicardium/coronary vessels and thin myocardium; therefore, coronary vessels observed in the chimeric heart mainly originated from the transplanted SV with the PEO (Takahashi et al., 2014) . 
| Organ culture
| Immunohistochemistry
Embryos or hearts were fixed in 4% paraformaldehyde in PBS for 30 min at room temperature (for anti-WT1 staining) or 3 hr at 4°C
(for other antibodies). After extensive washing in PBS, samples were equilibrated in graded series of sucrose in PBS (7%, 15%, 20% W/V) and embedded in optimum cutting temperature (OCT) compound (Sakura, Tokyo, Japan) and frozen in liquid nitrogen. Frozen sections were cut using a cryostat and mounted on slides. After being rinsed in PBS, sections were blocked with 1% bovine serum albumin (BSA)/ PBS for 1 hr at room temperature, incubated with a primary antibody for 2 hr at room temperature, rinsed with PBS, and incubated with a secondary antibody for 2 hr at room temperature followed by nuclei staining with 4′,6-diamino-2-phenylindole dehydrochloride (DAPI) for 20 min. After washing in PBS, samples were mounted and observed using a confocal laser microscope (Leica, Wetzlar, Germany) or conventional fluorescence microscope equipped with cooled CCD camera (Olympus, Tokyo, Japan).
Cultures were drained of medium, rinsed with PBS, and fixed with 4% paraformaldehyde/PBS for 30 min at room temperature. After washing with PBS, samples were blocked with 1% BSA/PBS containing 0.1% Triton X-100 (PBST) for 1 hr and incubated with a primary antibody for 2 hr at room temperature. Samples were rinsed with PBS, incubated with a secondary antibody, and the nuclei stained with DAPI. After washing, the samples were mounted in mounting medium and observed. Using a Fluo Render (University of Utah, UT, USA), confocal images were stacked in the z-axis direction and cross-sectional images were reconstructed.
| Antibodies
The following primary antibodies were used: mouse monoclo- kindly donated Dr Kobayashi, Kagawa University, Kagawa, Japan) (Shishibori, Yamashita, Bandoh, Oyama, & Kobayashi, 1996) , and anti-calponin (mouse monoclonal, clone CP93, 150×, Sigma-Aldrich).
Secondary antibodies were: TRITC-conjugated goat anti-mouse IgG1
(cat #1070-03, 100×, Southern Biotech, AL, USA), TRITC-conjugated goat anti-mouseIgG2a (cat #1080-03, 100×, Southern Biotech), Alexa 
| Counting labeled cells and statistical analysis
Using an 
| RESULTS
| The PEO consists of at least two cellular populations in origin
At first we examined whether ECs of the SV contributed to the cel- Note that panels d and e are daughter sections. Ao, ascending aorta; LA, left atrium; LV, left ventricle, PA, pulmonary trunk; scale bar, 100 μm (a4, b4, c4, d, e); 50 μm (b1-3); 25 μm (a1-3, c1-3)
SV endothelium, were observed in the PEO core-mesenchyme (white arrowheads in Figure 2a) . In histological sections, 76% ± 12% of the 
(yellow arrowheads in Figure 2b ). CFSE-negative/WT1-negative cells were observed within the PEO (white arrowheads in Figure 2b) .
Surprisingly, approximately 5% of CFSE-positive surface mesothelial cells showed negative or weak anti-WT1-immunoreactivity (arrows in Figure S5 ). These results suggested that the PEO consisted of at least two cellular populations in origin, one comprising SV endotheliumderived cells and the other mesothelium-derived cells.
| SV-derived ECs contribute to coronary vessels in the ventricular free wall
To investigate whether SV-derived ECs contributed to coronary vessels, quail PEOs with SV, in which the ECs had been labeled with EGFP-Tol2 or DiI-LDL, was orthotopically transplanted into PEOcauterized host chick embryos (Figure 1a) . After re-incubation, the Figure 3a ). At stage 27-29 (E5-6), QH1-positive cells, some of which had EGFP, showed a strand-like structure, and these vessel-like structures were found in the subepicardial space and myocardium of the atrioventricular canal and ventricular free wall (arrowheads in Figure 3b ,c). At stage 31-34 (E7-8), coronary arteries (stems) connected with the aortic sinuses. QH1-and/or EGFP-positive cells were found in ECs of both the coronary artery stem (arrowheads in Figure 3d ) and cardiac vein (arrows in Figure 3e ). Coronary vessels develop closely associated with cardiac lymphatics, however PEO does not contribute to lymphangioblasts (Wilting et al., 2007) .
Observations suggested that quail SV ECs contributed to coronary
ECs in the ventricular free wall including the coronary artery stem and cardiac vein in the host chick heart.
| Cultured SV ECs migrate through the PEO and maintain endothelial character
We next investigated whether ECs of SV were capable of migrating 
| Surface mesothelial cells of the PEO contribute to the coronary smooth muscle but few of them to ECs
To examine whether PEO mesothelial cells contributed to coronary ECs, quail PEOs, in which mesothelial surface cells had been labeled with EGFP-Tol2 or CFSE, was transplanted orthotopically into PEOcauterized host chick embryos (Figure 1b) . The chimeric embryos were re-incubated and heart sections were stained with an anti-QH1
antibody or anti-SMA antibody. In stage 23 (E4) chimeric hearts, EGFP-positive cells and QH1-positive cells were observed in the epicardium/subepicardial layer of the dorsal atrioventricular groove. Figure 5a ). In stage 29 (E6) hearts, EGFP-positive cells were observed in the epicardium/subepicardial layer at the atrioventricular groove (Figure 5b ), dorsal ventricular wall, and conotruncal base. Some EGFP-positive cells with a QH1 epitope were recruited into the QH1-positive vessel-like structures (arrowheads in Figure 5b ). In stage 34
Some of EGFP-positive cells had a QH1 epitope (arrowheads in
(E8) hearts, EGFP-positive cells were observed in the epicardium, subepicardial, and myocardial layers (Figure 5c,d) . Many of these cells expressing SMA were incorporated into the SMA-positive smooth muscle layer of the coronary artery (arrows in Figure 5c ). Some EGFP/ QH1-positive cells were incorporated into the coronary artery and cardiac vein (arrowheads in Figure 5d ). In tissue sections of stage 34
hearts, the percentage of SMA-positive cells in EGFP-positive cells was much greater than that of QH1-positive cells ( Figure S3 ). These results suggested that most surface mesothelial cells of the PEO differentiated into smooth muscle cells but some of them also differentiated into ECs.
| Cultured PEO mesothelial cells differentiate into cells with smooth muscle markers but only a small population gained endothelial character
We next examined whether mesothelial cells of the PEO were capable of differentiating into ECs in culture. CFSE-labeled chick or quail PEOs as described previously (Dettman et al., 1998) .
| QH1-positive subepicardial cells originated mainly from SV endothelium
The above experiments suggested that SV ECs and PEO surface mesothelial cells contributed to coronary endothelium. We next 
| Ventricular endocardium contributes to the septal artery
We next examined whether ventricular endocardium contributed to coronary vessels in the chick heart. Unlabeled quail PEO with SV was orthotopically transplanted into PEO-cauterized chick hearts, in which the endocardium had been transfected with EGFP-Tol2 (Figure 1d ). In Both EGFP-(arrowheads) and QH1-positive (arrows) ECs were observed in dorsal septal arteries. Ao, aorta; LA, left atrium; LV, left ventricle; PA, pulmonary artery; RA, right atrium; RV, right ventricle; Scale bar, 250 μm (a4, b4, c4, e4, f4); 100 μm (a1-3, b1-3, c1-3, d4, g4); 25 μm (d1-3, e1-3, f1-3, g1-3) hearts) (Lindsay & Smith, 1965) , which had an SMA-positive medial layer (Figure 8d1, f1) . The endothelium of these main coronary arteries had both QH1-positive (quail SV origin, arrows in Figure 8e ,g) and EGFP-positive ECs (chick ventricle origin, arrowheads in Figure 8e ,g).
The percentages of QH1-or EGFP-positive ECs in the coronary endothelium were calculated, in which the vascular segment was more than 100 μm in histological sections (Figure 9 ). The result showed that 50%-100% (mean 72%) of ECs in the coronary stems had QH1 immunoreactivity (SV derived cells) and the percentages of QH1-positive ECs were significantly high in both right and left coronary stems. In the dorsal segment of the septal artery 47% of ECs had QH1, whereas the rates were 14% in medial and 20% in the ventral segments. Less than 20% of ECs contained detectable amounts of EGFP in either the coronary stem or septal artery, and unlabeled ECs were predominant in the medial and ventral septal arteries. The origin of unlabeled coronary ECs was uncertain; however, the ventricular endocardium was a candidate for the source of unlabeled ECs rather than the host SV/ PEO, because the host PEO was cauterized and 90% of the coronary ECs in the ventricular free wall were transplanted quail SV in origin ( Figure S4 ). These observations suggested that SV ECs were the major source of coronary stem and coronary vessels in the ventricular free wall, whereas the ventricular endocardium contributed mainly to the ventricular septum. Schematic representations of the sources of coronary ECs were shown in Figure 10 .
| DISCUSSION
| PEO consists of at least two distinct tissue compartments in origin
Our dye-labeling experiments showed that the mature PEO consisted of at least two distinct cellular populations, which were CFSE-labeled surface mesothelial cells highly expressing WT1, and DiI-LDL-labeled SV-derived inner mesenchymal-like population. In the mouse PEO, there are three genetically distinct cellular compartments, in which Wt1/Tbx18-, Scleraxis-, and Semaphorin3D-expressing cells are identified (Katz et al., 2012) . Wt1-positive surface PEO cells differentiate into epicardium, smooth muscle cells, and interstitial cells. This cellular population is also required to form the coronary arterio-venous connection (Cano et al., 2016) . Scleraxis-positive but Wt1-negative mesothelial cells are observed mainly in the surface of the PEO and are competent to give rise to coronary ECs (Katz et al., 2012) . at the onset of/during PEO protrusion ( Figure S2 ). However, we could not rule out the possibility that the liver bud-derived ECs contribute to the PEO in avian species (Cossette & Misra, 2011) , because there is no specific marker to identify the liver bud-derived angioblasts. The PEO is a transient but important structure because it provides epicardium, interstitial cells, and coronary vessels to maintain myocardial growth and maturation (Gittenberger-de Groot, Vrancken Peeters, Bergwerff, Mentink, & Poelmann, 2000; Pennisi, Ballard, & Mikawa, 2003; Takahashi et al., 2014) . However, little is known about the molecular and cellular mechanisms underlying the specification/determination and early development of the PEO (Niderla-Bielinska et al., 2015) . Our in vivo and in vitro analyses clarified that the PEO consists of at least two cellular populations in origin, one was an SV-derived inner population giving rise to coronary ECs in the ventricular free wall, and the other was a surface mesothelial population giving rise to epicardium, vascular smooth muscle cells, and coronary ECs.
| SV is a major source of coronary ECs in ventricular free wall
Prior to 2000, the origin of coronary ECs had been investigated using quail-chick chimeras (co-transplantation of PEO and SV), retrovirus cell tracing, and fluorescent dye labeling in avian species.
These experiments are spatial labeling but not cell-or tissue-specific labeling because the PEO contains at least two distinct compartments in origin. Therefore, results from these experiments concluded that the PEO or PEO-derived epicardium is the major source of coronary ECs (Mikawa & Gourdie, 1996; Pérez-Pomares et al., 2002; review, Reese, Mikawa, & Bader, 2002) . Our tissue-specific labeling with quail-chick chimera and culture experiments supported the previous view and provided further evidence that the SV ECs contributed PEO core mesenchyme and later coronary endothelium in the ventricular free wall. The surface mesothelial cells of the PEO F I G U R E 9 Endothelial fractions in coronary stem and septal artery. Quail PEO with SV was orthotopically transplanted into PEO-cauterized chick hearts, in which the ventricular endocardium had been transfected with EGFP-Tol2. At stage 35, chimeric hearts were stained with QH1, and the percentage of QH1-or EGFPpositive ECs was counted manually in the coronary endothelium, in which the vascular segment was more than 100 μm in histological sections. *p < .05; **p < .01 (Mann-Whitney U-test after Bonferroni correction); NS, not significant; Red bar, % of QH1-positive ECs; green, EGFP-positive ECs; gray, unlabeled ECs; n, number of endothelial segments examined contributed to smooth muscle cells but few of them to ECs. Our labeling experiment showed that the ratio of the SV-derived population to the PEO-mesothelium-derived population in the subepicardial QH1-positive cells was 9:1 ( Figure 7 ). This ratio is consistent with mouse lineage tracing experiments showing that 70%-80%
of coronary ECs in the ventricular free wall originates from the SV (Zhang et al., 2016) . Mouse genetic approaches have shown that the main source of coronary ECs is the SV (Chen et al., 2014; RedHorse et al., 2010; Tian et al., 2013 Tian et al., , 2015 Wu et al., 2012; Zhang et al., 2016) . The SV-derived ECs migrate through the subepicardial space, dedifferentiate and redifferentiate into venous and arterial ECs via unknown signaling possibly involving VEGF, Shh, FGF, and Ang1 (Nakajima & Imanaka-Yoshida, 2013; Red-Horse et al., 2010; Tian et al., 2013 Tian et al., , 2015 Wu et al., 2012) . In our culture experiment, SV-derived cells had QH1 epitopes in 37% of cells after 48 hr in culture, subsequently they expressed QH1 in 80% of cells after 96 hr in culture. These results suggested that the SV-derived migrating cells initially dedifferentiated and then redifferentiated into ECs. Another possibility is that the cells migrating from the SV are endothelial progenitors, because the SV endothelium consists of heterogeneous populations (Arita et al., 2014) . Our in vivo and in vitro observations suggested that SV ECs are incorporated into the developing PEO, spread over the ventricular surface together with the epicardium, and contribute to coronary vessels in the ventricular free wall including coronary stems.
| Ventricular endocardium contributes mainly to the septal artery
In our quail-chick chimeras, in which unlabeled quail SV with the PEO was co-transplanted to endocardial-EGFP-labeled chick heart, EGFP-positive ECs were found in the septal artery and coronary stem, whereas only a few EGFP-positive cells were observed in the ventricular compact wall. In these chimeric hearts, QH1-negative/ EGFP-negative ECs were found in the septal arteries. This may be due to methodological limitations of the Tol2-mediated EGFP expression system, in which the transfection efficiency was low in the ventricular endocardium ( Figure S1b ,e). In these chimeric hearts, 90% of the coronary ECs in the ventricular compact wall were QH1-positive cells originating from the transplanted quail SV ( Figure S4) ; therefore, the QH1-negative/EGFP-negative coronary ECs in the ventricular septum were thought to originate from the host ventricular endocardium rather than the host SV. This result was consistent with that in mice, in which ventricular endocardium contributes to ventricular septum, whereas SV contributes to ventricular free wall (Chen et al., 2014; Red-Horse et al., 2010; Tian et al., 2013 Tian et al., , 2015 Zhang et al., 2016) .
EGFP-positive ECs were also found in the coronary artery stem. This observation was consistent with that in mice, in which the ventricular endocardium contributes to the ventricular free wall of the ventral cardiac base (Zhang et al., 2016) . Another mouse model showed that the ventricular endocardium is a major source of coronary arteries not only in the ventricular septum but also the ventricular free wall (Wu et al., 2012) . The discrepancy between these two observations in the mouse models may be attributed to the genes that drive Crerecombinase in target cells of interest, because the genes that drive
Cre-recombination in cells are not exclusively cell-type specific (Tian et al., 2015; Zhang et al., 2016) . In the neonatal mouse heart, ventricular endocardium differentiates into subendocardial coronary vasculature (Tian et al., 2014 ; our preliminary experiment suggested a similar phenomenon in the avian heart, Figure S6 ). Taken together with these observations, it appears plausible that the ventricular endocardium contributes to the coronary vessels in the ventricular septum as well as a part of the coronary stems.
In conclusion, despite the methodological limitation, relatively low labeling efficiency of EGFP-Tol2 system, our results strongly suggested that: (i) SV are the major source of coronary ECs of the ventricular F I G U R E 1 0 Schematic representations of the sources of coronary ECs in avian fetal heart. (a) Ventricular septum is shown from the right ventricle (right ventricular free wall is removed). (b) Cross-section of the ventricles. In the ventricular free wall, coronary ECs originate from SV endothelium (approximately 80%) and PEO surface mesothelium. In the ventricular septum, coronary ECs originate from the ventricular endocardium (approximately 70%-80%) and SV endothelium in the middle to ventral region, while SV endothelium and the ventricular endocardium evenly contribute to the dorsal region. Ao, ascending aorta; LV, left ventricle; PA, pulmonary artery; RV, right ventricle; TV, tricuspid valve free wall including the coronary stems; (ii) the ventricular endocardium contributes mainly to septal coronary vessels; and (iii) the surface mesothelial cells of the PEO contribute to the coronary smooth muscle cells but few of them to coronary ECs.
